West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.

The “'easy open' pull tab can lid on limited products encountered a manufacturing defect that may compromise the integrity of ...

A major recall of canned tuna sold in dozens of states has been issued amid concerns that a packaging defect could ...

Tuna sold in 26 states and in Washington, D.C., was recalled over concerns that it may have been contaminated. The stores ...

The Hims & Hers version of the weight-loss drug is a compounded drug, essentially a mixture of individual drugs that creates ...